Remote ischemic conditioning

Mechanism

Related News

Experimental study finds remote ischemic conditioning may protect the heart during anthracycline treatment

May 20, 2026

An experimental study found remote ischemic conditioning protected the heart during anthracycline treatment in tumor-bearing mice without reducing antitumor efficacy. The work supports the ongoing RESILIENCE clinical trial in cancer patients.

Heart Protection During Chemotherapy Achieved Without Reducing Cancer Treatment Effectiveness

Mar 02, 2026

A CNIC study demonstrates that remote ischemic conditioning can protect the heart during anthracycline chemotherapy without compromising antitumor efficacy, while researchers explore additional methods to manage chemotherapy side effects.